VALENCIA, Calif., March 20, 2013 – Advanced Bionics (AB), a global leader in cochlear implant technology and a company of the Sonova Group, announced today that it received FDA, Health Canada and TÜV approval for the global distribution of HiRes Optima™* sound processing. The world’s newest sound strategy for cochlear implant recipients, HiRes Optima delivers optimized battery life with the same great performance as AB’s patented HiRes Fidelity 120™* processing. AB cochlear implant recipients using this new technology enjoy an average improvement of 55% in battery life, giving them considerably more time to hear their world before needing to change a battery.
part of a company-wide commitment to providing the best performance,
Advanced Bionics continually innovates sound processing technology to
help recipients experience as close to normal hearing as possible. AB
built HiRes Optima processing on the HiRes Fidelity 120 platform to
benefit from its built-in performance capabilities. As the industry’s
only sound strategy that uses 120 spectral bands to deliver five times
more sound resolution than any other cochlear implant system, HiRes
Fidelity 120 has been developed to reveal all the dimensions of sound,
from the rich layers of music to the subtle nuances of tone during a
conversation. HiRes Optima provides the same rich and detailed sound
with an improved battery life.
“Nothing on the market can
compete with the sound quality from our HiRes Fidelity 120 technology.
To deliver the same performance and substantially increase battery life
for our recipients is a great accomplishment,” said Hansjuerg Emch,
President of Advanced Bionics and Group Vice President of the Sonova
Medical Division within which AB resides. “HiRes Optima perfectly
represents the intense effort and engineering expertise that make AB the
leading innovator in our industry.”
Benefiting from the HiRes Fidelity 120 platform, HiRes Optima also delivers AB’s proprietary current steering technology.
Other implants use a single current source to stimulate only one
electrode at a time, limiting the number of potential spectral bands.
Like AB’s HiRes Fidelity 120, HiRes Optima has multiple current sources,
enabling two or more electrodes to be stimulated at the same time. This
simultaneous stimulation allows current to be “steered” between
electrodes, giving AB cochlear implant recipients the opportunity to
hear more pitches. Recipients using research software have demonstrated
the ability to perceive up to 450 pitches.1
HiRes Optima will be available for use with AB’s next-generation sound processor as well as Neptune™ and Harmony™ processors.
more information about HiRes Optima sound processing, or any Advanced
Bionics product, contact a local AB representative or visit AdvancedBionics.com.